Aller au contenu principal
Article language
STOLL/SleepBase/Body and sleep

Body and sleep

Bed temperature and nocturnal growth hormone secretion

Thermal comfort is not a proven hormone enhancer

Your gateway to sleep knowledge

Welcome to SleepBase.

Use your STOLL access to explore in-depth research on better sleep.

No access yet? Speak to your STOLL advisor.

Explore and understand

Discover connections.

Choose an approach, then explore each step with your mouse, keyboard or touch.

Room temperature

Potential contribution

Describes environment

Qualitative interpretation. These connections do not establish causality; no product measurements are simulated.

Change perspective

What does this mean in practice?

More deep sleep indicated

A device reports a change in sleep stages.

Putting it in context

No growth hormone value can be calculated from this.

Three schematic night profiles

Model · no product measurement
23 Clock

Synthetic standardised curves. No blood values, no personal reference ranges. GH is schematically coupled to sleep onset; melatonin and cortisol remain on a simplified circadian axis. Real profiles are pulsatile and individually different.

20:00 to 12:00 the following dayEach curve normalised separately · no concentrationMelatoninGHCortisol

Only the modelled GH pulse is shifted with sleep onset. Real hormones interact in a more complex way and show individual pulses.

The research question

Understanding the findings.

Growth hormone is secreted in a pulsatile manner and is closely related to sleep and other physiological influences. Thermal stress can alter sleep and hormonal processes. However, no generally optimal bed temperature for increasing growth hormone secretion can be derived from this. This research examines the link between temperature, sleep architecture, and endocrine metrics. The reliable practical deduction is the avoidance of individually disturbing heat or cold; a promise of targeted hormonal regeneration through a material goes beyond the available evidence.

Pulsatile secretion instead of a constant nocturnal value

The concentration of growth hormone changes significantly over time. A single blood value is therefore only of limited significance for the total nocturnal secretion. Age, gender, metabolic state, and sleep progression influence interpretation. An investigation must therefore provide for multiple time points and a suitable evaluation strategy.

Sleep stages and hormone secretion can be temporally related without every change in a sleep stage being allowed to be translated proportionally into a hormone change. A device that estimates more deep sleep does not measure growth hormone. The chain of reasoning 'cooler mattress, more deep sleep, more growth hormone, better regeneration' contains several independent hypotheses.

A direct older temperature study

A study from 1976 recorded sleep, rectal temperature, and several hormones in eight healthy men under normal, elevated, and reduced temperature conditions. The reported findings show that both heat and cold stress can be associated with changes in endocrine activity. [1]

The small sample size, the age of the study, and the specific experimental design limit the transfer to products today. It does not provide a temperature value that guarantees the highest growth hormone secretion for all bedrooms, blankets, and persons. In particular, a change in the environment or body temperature is not identical to a small change in the material on the mattress surface.

Room, skin, core body and bed surface

Temperature has different measurement locations. Cooler room air can occur simultaneously with warm feet and a sufficiently insulated body surface. An active topper changes different conditions locally than an air conditioning system. The body also reacts to temporal changes and to the distribution of heat across different regions.

Research on conductive heat dissipation via mattresses investigates body temperature and sleep parameters. [2] These works can prove the relevance of thermal conditions, but do not automatically measure the desired endocrine effect. For a statement about growth hormone, hormone measurement would have to be an explicit part of the experiment. A pleasant surface is a sensible comfort endpoint, but not a substitute marker for hormone secretion.

Why more cooling is not automatically better

A blanket strategy of maximum cooling overlooks individual cold sensitivity and the possibility of thermal discomfort. Even a person who finds warmth pleasant when falling asleep may prefer a different setting later on. The duvet, clothing, body position, and room climate jointly determine the temperature that actually develops at the skin.

A sensible product approach therefore works with comfort and tolerance, not with a claimed universal hormonal curve. For active systems, settings should be applied gradually and in a traceable manner. Automatic programmes require a clear distinction between measured temperature, estimated sleep stage, and actually proven physiological benefit.

The missing bridge to regeneration

Even a proven change in nocturnal hormone secretion would not yet be complete evidence of better muscle growth, skin regeneration, or long-term health. These endpoints depend on many other factors and would need to be investigated directly. A short-term biomarker finding must therefore not be converted into a broad claim of performance enhancement or rejuvenation.

For STOLL, the precise statement is more attractive: A thermally suitable bed can reduce disturbing heat or cold and thus create favourable sleep conditions. Whether a specific system additionally influences growth hormone remains a separate research question. In targeted research, no robust general evidence was identified that derives a reproducible hormone increase for the broad customer base from a specific bed temperature.

Cortisol, growth hormone and melatonin over time

The three hormones do not follow the same clock. Melatonin indicates the biological night under suitable lighting conditions. Cortisol shows a circadian rhythm with a typical rise towards the biological morning; the awakening response is additionally to be distinguished from the actual nocturnal progression. Growth hormone is secreted in a pulsatile manner and is often associated with early sleep and slow-wave activity. Controlled studies show that sleep deprivation and shifted sleep alter these relationships differently. [4] An early GH pulse is therefore neither the same size for every person nor tied exclusively to a fixed time.

A study under constant routine helps to separate circadian influences from behaviour. [5] However, such conditions are artificial. For the accompanying page, only standardised schematic profiles are therefore shown. Their height does not possess a unit such as ng/ml and is not a medical reference range. Light, age, sex, medication, and metabolic status can alter real progressions. A bed temperature intervention would first have to measure sleep and thermal state and then verify whether a defined hormonal endpoint follows. It must not be advertised as hormone optimisation based on a model curve.

Time resolution and the danger of a single value

A hormone profile consists of a progression, not a representative moment. If a sample is coincidentally close to a secretion peak, it may appear higher than a sample on another night, even though the overall nocturnal secretion is similar. The timing relative to falling asleep and the frequency of the samples are therefore essential.

For a temperature comparison, it must also be taken into account whether the sampling disturbs sleep. A technically precise laboratory determination cannot compensate for an unsuitable experimental setup. Convincing work therefore describes both analytical quality and the influence of the measurement on the condition being investigated. For product communication, this means that a single spectacular hormone figure without a complete nocturnal protocol has little informative value.

Hypothetical case of a cooling premium topper

A topper is advertised with more deep sleep. From this, an increased growth hormone secretion is additionally derived in sales. This second step is not automatically covered by the first. First of all, it must even be clarified whether deep sleep was measured directly or merely estimated by an algorithm.

STOLL should trace the original study back to the actually recorded endpoint. If no hormones were measured, the statement remains limited to temperature, comfort, or sleep parameters. The topper can still be useful. Its benefit does not require additional endocrine justification that the data does not support. This precise limitation protects the scientific credibility of the entire offering.

From biomarker to personal benefit

A higher value is not fundamentally better when it comes to biological quantities. Physiological systems possess temporal regulation and individual differences. Product development should therefore not attempt to maximise a single hormone quantity without a clinical basis.

For customers, less disturbing sweating, better sleep continuity, or more pleasant waking are understandable goals. If these are actually improved, the benefit can be described directly. An additional statement regarding muscle growth, rejuvenation, or hormonal optimisation requires its own studies. The document therefore treats such statements as separate evidentiary questions.

Benefits and limitations

Approaches in comparison.

ApproachPotential contributionLimits of the evidence
Room temperatureDescribes environmentNot the same as skin or core body temperature
Deep sleep estimationCan map sleep progressionNo hormone measurement
Growth hormone profileDirect endocrine endpointMultiple measurements and time reference required
RegenerationTo be defined clinically or functionallyCannot be derived from a single hormone number

What can be measured.

MetricTestImportant limitation
TemperaturesMultiple measurement locations and time seriesSeparate bed surface and core body temperature
Sleep stagesPolysomnographyConsumer estimation is not a reference
Hormone profileSerial laboratory determinationsConsider pulsatility
TolerabilityHeat, cold and interruptionsDo not subordinate comfort to a biomarker

From research to application

Guidance for practice.

A reliable test plan

A dedicated scientific trial would have to define thermoneutral, warmer, and cooler conditions in advance and conduct them under medical supervision. Repeated blood draws can influence sleep itself and therefore require a suitable method. Nutrition, exercise, sleep times, and relevant medication are part of the control. The primary endpoint would be a pre-determined feature of the nocturnal hormone profile. Sleep and comfort would be recorded in parallel. A subsequent claim regarding muscle or skin regeneration would require an additional long-term trial with exactly these endpoints.

Implications for customer advice

During consultation, ask about thermal comfort, night sweats, and feelings of cold. Active temperature control can be set according to personal tolerability. Statements such as 'promotes the secretion of growth hormone' should be avoided without direct product-specific data. In the case of suspected hormonal disorders, a medical examination is responsible. The appropriate mattress is not selected based on a promised hormone maximum, but based on verifiable sleep and comfort criteria.

Evidence and practical implementation

For classification, the primary criterion is whether the source examines the exact question asked. A technically precise material measurement can be highly informative for a material property while saying little about sleep or long-term health. A clinical study may show a relevant benefit, but only for the group of people, construction, and duration of use studied. Proximity to the concrete question is therefore just as important as the study design.

Subsequently, comparison conditions, sample size, observation duration, and potential biases are considered. Blinding is often difficult with bedding. Expectations, habituation, and the sequence of tested variants can influence results. In the case of manufacturer funding, transparency and independent replication are particularly helpful; funding alone does not decide for or against the validity of a finding. Small pilot studies are primarily used to formulate a question more precisely and to plan a larger trial.

Statistical significance is not the same as practical importance. A small difference can be mathematically detectable without having a tangible benefit for the person in question. Conversely, a relevant individual improvement may remain statistically uncertain in a small group. Therefore, effect size, uncertainty, and everyday relevant endpoints are assessed together. A blanket score would obscure these differences. The interactive companion page consequently does not use fabricated health scores or simulated figures that appear like measured material data.

For implementation, a concrete goal is first defined, and then the smallest reasonably testable change is selected. The initial state, construction used, and observation period are documented. Feedback should capture both the desired benefit and possible new disadvantages. If several components are changed simultaneously, the attribution of success remains uncertain. An individual comparison can improve personal selection but does not replace a general efficacy study.

A supplier proof should concern the model actually offered and the intended use. Deviations in the cover, topper, base, care, or software can alter the transferability. The consultation openly states such limitations and formulates only the performance covered by data or immediate observation. For medical or legal questions, the relevant professional assessment remains necessary. The practical recommendation of this document is a basis for decision-making and not an individual diagnosis.

Research you can trace

Sources and context.

Research methods and limitations

This paper is a targeted narrative research as of 30 September 2026. The starting point is the specific topic question, scientific publications, and, for technical or legal questions, the relevant original sources. The Word documents provided by the client serve as templates for the professional structure and comparative presentation. Their individual statements have not been adopted without verification. This research is not a systematic comprehensive survey, a meta-analysis, or a product certification.

The sources were checked via accessible publication sites, bibliographic datasets, and available excerpts. A complete article was not accessible for every source. Where only an abstract or excerpt was available, the description is limited to the information discernible therein. Figures are only mentioned within their study context; missing details are not supplemented. A phrase such as "no reliable evidence identified" describes the result of this targeted research and does not prove that no such work exists worldwide.

The source numbers in the text refer to the list at the end. Directly examined findings, mechanistic considerations, and the author's own practical deductions are linguistically separated. Hypothetical cases illustrate the decision-making logic; they are not documented customer experiences. The suggested test plans are original designs. They do not establish a binding standard or a medical treatment process. Statements about a product class are not automatically transferred to individual models.

English translation of the German original. Bibliographic references and Word files remain in their original language.

SleepBase by STOLL · Research status: 30 September 2026
Scientific interpretation with sources and limitations. Not an individual medical diagnosis.